A study to evaluate the efficacy, safety, and tolerability of Olpasiran (AMG890, a small interfering RNA) in subjects with elevated lipoprotein(a).
OCEAN(a)-DOSE on ClinicalTrials.gov
Contact Us about OCEAN(a)-DOSE
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School
TIMI STUDY GROUP 